Evidence map›Paper›PMID 34930544›Full record

ArticleJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2021

Remote monitoring in telehealth care delivery across the U.S. cystic fibrosis care network.

Thida Ong, Aricca D Van Citters, Christopher Dowd, Jason Fullmer, Rhonda List, Shine-Ann Pai, Clement L Ren, Peter Scalia, George M Solomon, Gregory S Sawicki

Open access · hybridAbstract read
PubMed Publisher
In one paragraph

Article in Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Transforming Care Models in Cystic Fibrosis: A Review.Healthcare (Basel, Switzerland) · 2025
    Review
  5. Home sputum collection forERJ open research · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Considerations for the use of inhaled antibiotics forBMJ open respiratory research · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Home Spirometry in Children with Cystic Fibrosis.Bioengineering (Basel, Switzerland) · 2023
    Article
  15. A year in review: Real world evidence, functional monitoring and emerging therapeutics in 2021.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2022
    Review
  16. Design and methods for understanding the state of cystic fibrosis care amid the COVID-19 pandemic.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  17. Digital healthcare in cystic fibrosis. Learning from the pandemic to innovate future care (Commentary).Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 8 institutions in 1 country.

Thida OngDivision of Pulmonary and Sleep Medicine, Seattle Children's Hospital, Seattle, WA, United States. Electronic address: thida.ong@seattlechildrens.org.
Aricca D Van CittersThe Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, United States.
Christopher DowdCystic Fibrosis Foundation, Bethesda, MD, United States.
Jason FullmerDCMG Pediatric Pulmonology & Sleep Medicine, Dell Children's Medical Group, Austin, TX, United States.
Rhonda ListDivision of Pulmonary and Critical Care, University of Virginia, Charlottesville, VA, United States.
Shine-Ann PaiMarnie Paul Specialty Care Center, Dell Children's Medical Center of Central Texas, Austin, TX, United States.
Clement L RenDivision of Pulmonary and Sleep Medicine, Children's Hospital of Philadelphia, Philadelphia, PA, United States; Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
Peter ScaliaThe Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, NH, United States.
George M SolomonUniversity of Alabama at Birmingham, Birmingham, AL, United States.
Gregory S SawickiDivision of Pulmonary Medicine, Boston Children's Hospital, Boston, MA, United States.
Dartmouth Institute for Health Policy and Clinical Practice · USDell Children's Medical Center of Central Texas · USBoston Children's Hospital · USChildren's Hospital of Philadelphia · USCystic Fibrosis Foundation · USSeattle Children's Hospital · USUniversity of Alabama at Birmingham · USUniversity of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCystic fibrosis (CF) programs and people with CF (PwCF) employed various monitoring methods for virtual care during the COVID-19 pandemic. This paper characterizes experiences with remote monitoring across the U.S. CF community.

methodsThe CF Foundation (CFF) sponsored distribution of home spirometers (April 2020 to May 2021), surveys to PwCF and CF programs (July to September 2020), and a second program survey (April to May 2021). We used mixed methods to explore access, use, and perspectives regarding the use of remote monitoring in future care.

resultsBy October 2020, 13,345 spirometers had been distributed, and 19,271 spirometers by May 2021. Programs (n=286) estimated proportions of PwCF with home devices increased over seven months: spirometers (30% to 70%), scales (50% to 70%), oximeters (5% to 10%) with higher estimates in adult programs for spirometers and oximeters. PwCF (n=378) had access to scales (89%), followed by oximeters (48%) and spirometers (47%), often using scales and oximeters weekly, and spirometers monthly. Over both surveys, some programs had no method to collect respiratory specimens for cultures associated with telehealth visits (47%, n=132; 41%, n=118). Most programs (81%) had a process for phlebotomy associated with a telehealth visit, primarily through off-site labs. Both PwCF and programs felt future care should advance remote monitoring and recommended improvements for access, training, and data collection systems.

conclusionsPwCF and programs experienced unprecedented access to remote monitoring and raised its importance for future care. Improvements to current systems may leverage these shared experiences to augment future care models.

Indexed as

COVID-19Cystic FibrosisHome Care ServicesSpirometryAdultChildDelivery of Health CareEquipment and SuppliesHealth Services AccessibilityHumansModels, OrganizationalMonitoring, PhysiologicNeeds AssessmentOximetryQuality ImprovementSARS-CoV-2Cystic fibrosisHome spirometryHome sputum collectionTelehealthTelemedicine

Identifiers

PMID34930544
OpenAlexW4200367629

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.